Ridgetech (FRA:7QL) YoY EBITDA Growth: -140.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7QL Ridgetech Inc FRA:7QL
39 GF Score
Price €20,304.00
GF Value €1,460,738.86
! 3 Warning Signs
View Full Analysis

What is Ridgetech YoY EBITDA Growth?

Ridgetech FRA:7QL 39 YoY EBITDA Growth is -140.50% as of Mar. 2026. GuruFocus rates FRA:7QL with a GF Score™ of 39/100 and a GF Value™ of €1,460,738.86. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ridgetech's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -140.50%.

Ridgetech's EBITDA per Share for the six months ended in Mar. 2026 was €-8.13.

Ridgetech YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ridgetech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ridgetech YoY EBITDA Growth Chart

Ridgetech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.78 -635.17 110.82 -69.80 -108.60

Ridgetech Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.26 260.82 -95.31 -98.41 -140.50
FRA:7QL
39GF Score
Ridgetech Inc FRA:7QL
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ridgetech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ridgetech's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(-10.89-126.649)/ | 126.649 |
=-108.60 %

Ridgetech's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(-8.132-20.079)/ | 20.079 |
=-140.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -140.50% mean?
Ridgetech (FRA:7QL) has a YoY EBITDA Growth of -140.50% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ridgetech and its competitors.
Is Ridgetech's YoY EBITDA Growth too high?
Ridgetech's current YoY EBITDA Growth is -140.50%. Overall, Ridgetech has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Ridgetech's YoY EBITDA Growth compare to DHTI and PMHS?
Ridgetech's YoY EBITDA Growth of -140.50% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ridgetech and its competitors. Ridgetech's current YoY EBITDA Growth is -140.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ridgetech stock overvalued right now?
Ridgetech (FRA:7QL) has a current YoY EBITDA Growth of -140.50%. The stock's GF Value™ is €1,460,738.86, compared to a current price of €20,304.00 — trading 98.6% below its estimated fair value. The current YoY EBITDA Growth is -140.50%. Ridgetech's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ridgetech (FRA:7QL), the current YoY EBITDA Growth is -140.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ridgetech (FRA:7QL) Overvalued in 2026?

Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued. The current stock price of €20,304.00 is trading 98.6% below its estimated GF Value™ of €1,460,738.86.

Key valuation signals for FRA:7QL:

  • YoY EBITDA Growth: -140.50%
  • GF Value™: €1,460,738.86 vs. price of €20,304.00 (98.6% below fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ridgetech Business Description

Other Exchanges RDGT:USA
Address 18th Street, 5th Floor, Building 6, No. 100, Baiyang Sub-district, Qiantang District, Zhejiang Province, Hangzhou, CHN, 310008
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
39GF Score

Get the complete analysis for FRA:7QL

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20,304.00
Price
€1,460,738.86
GF Value